Can mutations in ELA2, neutrophil elastase expression or differential cell toxicity explain sulphasalazine-induced agranulocytosis?
BMC Blood Disorders 2004, 4:5 doi:10.1186/1471-2326-4-5
Pre-publication versions of this article and reviewers' reports
|Original Submission - Version 1||05 Jul 2004|
|Resubmission - Version 3||22 Oct 2004|
|Reviewer's Report||03 Nov 2004|
|Resubmission - Version 5||02 Dec 2004|
|Published||02 Dec 2004|
Due to technical difficulties, the pre-publication history may be incomplete. If you require any further information please contact the journal.